Literature DB >> 12707047

Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.

Michiko K Oyoshi1, Hiroshi Nagata, Nobuhiro Kimura, Yu Zhang, Ayako Demachi, Toshiro Hara, Hirokazu Kanegane, Yoshinobu Matsuo, Tomohiro Yamaguchi, Tomohiro Morio, Atsuyoshi Hirano, Norio Shimizu, Kohtaro Yamamoto.   

Abstract

We recently established an Epstein-Barr virus (EBV)-positive gammadelta T-cell line from a nasal T/natural killer (NK)-cell lymphoma (Nagata H, Konno A, Kimura N, Zhang Y, Kimura M, Demachi A, Sekine T, Yamamoto K, Shimizu N: Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 2001, 97:708-713). Subsequently, we established two novel EBV-positive gammadelta T-cell lines from the peripheral blood of patients with chronic active EBV infection. Analysis of the terminal repeat of EBV showed that the three cell lines consisted of monoclonal populations, and flow cytometry showed that they had a common phenotype of gammadelta T cells: CD3(+) CD4(-) CD8(-) CD16(-) CD19(-) CD56(+) CD57(-) HLA-DR(+) T-cell receptor (TCR) alphabeta(-) TCR gammadelta(+). Analysis for the expression of TCR by flow cytometry showed that all three cell lines were Vgamma9(+)/Vdelta2(+), but negative for VgammaI, Vdelta1, or Vdelta3 TCR. Southern blot analysis for TCR genes showed that the three cell lines had a common rearrangement of Vgamma9-JgammaP and Jdelta3 genes. Polymerase chain reaction and sequence analysis of the junction between Vdelta and Jdelta genes revealed that the Jdelta3 genes were rearranged with the Vdelta2 genes. In contrast, none of the EBV-negative gammadelta T-cell lines, Molt-14, Peer, or Loucy, which were analyzed for controls, had Vgamma9 or Vdelta2 TCR, or a rearrangement of Jdelta3 genes. These results indicated that Vgamma9-JgammaP/Vdelta2-Jdelta3(+) gammadelta T cells were preferentially affected by EBV and expanded in patients with nasal gammadelta T-cell lymphoma and chronic active EBV infection. Jdelta3(+) gammadelta T cells are known to be a very minor population in gammadelta T cells of peripheral blood, whereas Vgamma9-JgammaP/Vdelta2-Jdelta1(+) cells are the major population. The close association of EBV with this particular gammadelta T-cell population may provide a key to the etiology of EBV-positive lymphoproliferative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707047      PMCID: PMC1851204          DOI: 10.1016/s0002-9440(10)64297-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  61 in total

Review 1.  Generation of human gammadelta T-cell repertoires.

Authors:  L D McVay; S R Carding
Journal:  Crit Rev Immunol       Date:  1999       Impact factor: 2.214

2.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

3.  Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus.

Authors:  H Nagata; A Konno; N Kimura; Y Zhang; M Kimura; A Demachi; T Sekine; K Yamamoto; N Shimizu
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

4.  Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection.

Authors:  H Nagata; T Numata; A Konno; I Mikata; K Kurasawa; S Hara; M Nishimura; K Yamamoto; N Shimizu
Journal:  Pathol Int       Date:  2001-10       Impact factor: 2.534

5.  Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.

Authors:  G Klein; D Purtilo
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

6.  Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.

Authors:  P Gaulard; P Bourquelot; P Kanavaros; C Haioun; J P Le Couedic; M Divine; M Goossens; E S Zafrani; J P Farcet; F Reyes
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

7.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

Authors:  L Quintanilla-Martinez; S Kumar; F Fend; E Reyes; J Teruya-Feldstein; D W Kingma; L Sorbara; M Raffeld; S E Straus; E S Jaffe
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

8.  Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA+ T-cell lymphoma containing linear, EBV DNA.

Authors:  V R Bonagura; B Z Katz; B L Edwards; D J Valacer; P Nisen; E Gloster; R Mir; P Lanzkowsky
Journal:  Clin Immunol Immunopathol       Date:  1990-10

9.  Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.

Authors:  T Okamura; Y Hatsukawa; H Arai; M Inoue; K Kawa
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

10.  Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype.

Authors:  Z Ravid; N Goldblum; R Zaizov; M Schlesinger; T Kertes; J Minowada; W Verbi; M Greaves
Journal:  Int J Cancer       Date:  1980-06-15       Impact factor: 7.396

View more
  9 in total

1.  Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells.

Authors:  Matthias Eberl; Hassan Jomaa; Adrian C Hayday
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

2.  Assay design affects the interpretation of T-cell receptor gamma gene rearrangements: comparison of the performance of a one-tube assay with the BIOMED-2-based TCRG gene clonality assay.

Authors:  Allison M Cushman-Vokoun; Solomon Connealy; Timothy C Greiner
Journal:  J Mol Diagn       Date:  2010-11       Impact factor: 5.568

3.  An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection.

Authors:  Chongfeng Xu; Junhong Ai; Qingxun Zhang; Ting Li; Xiaorong Wu; Zhengde Xie; Ziyuan Duan
Journal:  J Vis Exp       Date:  2018-03-30       Impact factor: 1.355

4.  The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.

Authors:  Weiyue Ding; Chong Wang; Yohei Narita; Hongbo Wang; Merrin Man Long Leong; Alvin Huang; Yifei Liao; Xuefeng Liu; Yusuke Okuno; Hiroshi Kimura; Benjamin Gewurz; Mingxian Teng; Shuilin Jin; Yoshitaka Sato; Bo Zhao
Journal:  J Virol       Date:  2022-09-12       Impact factor: 6.549

5.  Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions.

Authors:  Taizo Wada; Akiko Toga; Yasuhisa Sakakibara; Tomoko Toma; Minoru Hasegawa; Kazuhiko Takehara; Tomonari Shigemura; Kazunaga Agematsu; Akihiro Yachie
Journal:  Int J Hematol       Date:  2012-08-12       Impact factor: 2.490

6.  BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.

Authors:  Nenad Sejic; Lindsay C George; Rosemary J Tierney; Catherine Chang; Olga Kondrashova; Ruth N MacKinnon; Ping Lan; Andrew I Bell; Guillaume Lessene; Heather M Long; Andreas Strasser; Claire Shannon-Lowe; Gemma L Kelly
Journal:  Blood Adv       Date:  2020-10-13

7.  Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.

Authors:  Zakia Djaoud; Lisbeth A Guethlein; Amir Horowitz; Tarik Azzi; Neda Nemat-Gorgani; Daniel Olive; David Nadal; Paul J Norman; Christian Münz; Peter Parham
Journal:  J Exp Med       Date:  2017-05-03       Impact factor: 14.307

Review 8.  Epstein-Barr virus-associated lymphomas.

Authors:  Claire Shannon-Lowe; Alan B Rickinson; Andrew I Bell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

9.  Human Peripheral Blood Gamma Delta T Cells: Report on a Series of Healthy Caucasian Portuguese Adults and Comprehensive Review of the Literature.

Authors:  Sónia Fonseca; Vanessa Pereira; Catarina Lau; Maria Dos Anjos Teixeira; Marika Bini-Antunes; Margarida Lima
Journal:  Cells       Date:  2020-03-16       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.